Sera Prognostics, Inc. (SERA)
2.17
-0.01
(-0.46%)
USD |
NASDAQ |
Aug 26, 15:43
Sera Prognostics Price to Book Value : 1.441 for Aug. 26, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 1.448 |
| August 24, 2026 | 1.448 |
| August 21, 2026 | 1.421 |
| August 20, 2026 | 1.395 |
| August 19, 2026 | 1.322 |
| August 18, 2026 | 1.282 |
| August 17, 2026 | 1.295 |
| August 14, 2026 | 1.302 |
| August 13, 2026 | 1.335 |
| August 12, 2026 | 1.342 |
| August 11, 2026 | 1.322 |
| August 10, 2026 | 1.335 |
| August 07, 2026 | 1.375 |
| August 06, 2026 | 1.328 |
| August 05, 2026 | 1.328 |
| August 04, 2026 | 1.282 |
| August 03, 2026 | 1.395 |
| July 31, 2026 | 1.355 |
| July 30, 2026 | 1.395 |
| July 29, 2026 | 1.362 |
| July 28, 2026 | 1.348 |
| July 27, 2026 | 1.362 |
| July 24, 2026 | 1.362 |
| July 23, 2026 | 1.441 |
| July 22, 2026 | 1.382 |
| Date | Value |
|---|---|
| July 21, 2026 | 1.508 |
| July 20, 2026 | 1.395 |
| July 17, 2026 | 1.362 |
| July 16, 2026 | 1.461 |
| July 15, 2026 | 1.435 |
| July 14, 2026 | 1.315 |
| July 13, 2026 | 1.275 |
| July 10, 2026 | 1.308 |
| July 09, 2026 | 1.368 |
| July 08, 2026 | 1.362 |
| July 07, 2026 | 1.335 |
| July 06, 2026 | 1.388 |
| July 02, 2026 | 1.328 |
| July 01, 2026 | 1.348 |
| June 30, 2026 | 1.209 |
| June 29, 2026 | 1.048 |
| June 26, 2026 | 1.042 |
| June 25, 2026 | 1.042 |
| June 24, 2026 | 1.042 |
| June 23, 2026 | 1.065 |
| June 22, 2026 | 1.071 |
| June 18, 2026 | 1.013 |
| June 17, 2026 | 1.094 |
| June 16, 2026 | 1.077 |
| June 15, 2026 | 1.065 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Myriad Genetics, Inc. | 0.9768 |
| BioRestorative Therapies, Inc. | 1.827 |
| CareDx, Inc. | 6.153 |
| Natera, Inc. | 26.58 |
| Exagen, Inc. | 15.15 |
Price to Book Value Related Metrics
| PS Ratio | 1551.87 |
| Price | 2.17 |
| Earnings Yield | -30.58% |
| Market Cap | 85.58M |